RE:Phase 2 DMT Stroke Study Design Finalized Nice post, but do you really think they can raise the $4-5m to run such trial with market cap below $2M and raise $200k to cover maybe a month of burn.
even if they figured out a way to raise the $, there's no real intellectual property in my opinion. They are taking off the shelf drug and giving to stroke patients.
I guess a last attempt to drum up interest from incestors
They sign up Maxim who assume is now trickle out the shares they received for service. The spiral continues . . .